Professor Michael Beard

Professor

School of Biological Sciences

Faculty of Sciences, Engineering and Technology

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Associate Professor Michael Beard is head of the Viral Pathogenesis Research Laboratory (VPRL) at The University of Adelaide. He completed his PhD in molecular virology from the University of Queensland and after working in the USA with Stanley Lemon at UNC Chapel Hill he returned to Adelaide in 2002 and established the VPRL that focuses on the development of model systems to study complex cellular virus interactions with the ultimate aim to develop novel therapeutic strategies and understand how viruses cause disease. He has been continually funded by the NHMRC for 18 years. A main focus of his laboratory is the study of positive strand RNA viruses of the Flaviviridae family such as hepatitis C virus and other closely related viruses such as Dengue, West Nile Virus and more recently Zika virus. In particular his laboratory is interested in the innate immune response to viral infection and the host antiviral response through the expression of interferon stimulated genes (ISGs). Current projects use cutting edge molecular techniques such as, (i) CRISPR-related genome wide screens to identify novel host factors involved in viral life-cycles, (ii) development of human liver organoid cultures as a model of HBV infection and (iii) characterisation of the novel female hormonally regulated, interferon-epsilon in control of sexual transmission of ZIKV infection of the FRT and the development of novel therapeutics to modulate the innate immune environment of the FRT to limit sexually transmitted infections.

Career
Publications
Grants and Funding
Supervision
Professional Activities
Contact

Appointments

Date	Position	Institution name
2020 - ongoing	Head of Department, Molecular and Biomedical Science	The University of Adelaide
2016 - ongoing	Faculty Member	SAHMRI
2012 - ongoing	Associate Professor	The University of Adelaide
2010 - 2015	NHMRC Senior Reearch Fellow	The University of Adelaide
2005 - 2009	NHMRC RD Wright Research Fellow	SA Pathology
2002 - 2004	Royal Adelaide Hospital Florey Fellow	Institute of Medical and Veterinary Science
2000 - 2002	Assistant Professor (Research)	The University of Texas Medical Branch, Galveston
1997 - 1999	Postdoctoral Scientist	University of Texas Medical Branch, Galveston
1996 - 1997	Postdoctoral Scientist	University of North Carolina, Chapel Hill

Education

Date	Institution name	Country	Title
1996	The University of Queensland	Australia	PhD
1992	The University of Adelaide	Australia	BSc (Hons)
1983 - 1986	University of South Australia	Australia	Associate Diploma in Medical laboratory Science

Research Interests

Innate Immunity Medical Virology

Journals

Year	Citation
2024	Kirby, E. N., Montin, X. B., Allen, T. P., Densumite, J., Trowbridge, B. N., & Beard, M. R. (2024). CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. Innate Immunity, 30(2-4), 40-54. DOI
2023	Roennfeldt, A. E., Allen, T. P., Trowbridge, B. N., Beard, M. R., Whitelaw, M. L., Russell, D. L., . . . Peet, D. J. (2023). NanoFIRE: A NanoLuciferase and Fluorescent Integrated Reporter Element for Robust and Sensitive Investigation of HIF and Other Signalling Pathways. Biomolecules, 13(10), 1545-1-1545-16. DOI
2023	Lim, C. K., Romeo, O., Tran, B. M., Flanagan, D. J., Kirby, E. N., McCartney, E. M., . . . Beard, M. R. (2023). Assessment of hepatitis B virus infection and interhost cellular responses using intrahepatic cholangiocyte organoids. Journal of Medical Virology, 95(11), 16 pages. DOI
2023	Cheng, C., Ren, W., Miao, F., Chen, X., Chen, X., & Zhang, H. (2023). Generation of Fe<sup>IV</sup>=O and its Contribution to Fenton-Like Reactions on a Single-Atom Iron−N−C Catalyst. Angewandte Chemie - International Edition, 62(10), 10 pages. DOI Scopus134 Europe PMC17
2023	Coldbeck-Shackley, R. C., Romeo, O., Rosli, S., Gearing, L. J., Gould, J. A., Lim, S. S., . . . Beard, M. R. (2023). Constitutive expression and distinct properties of IFN-epsilon protect the female reproductive tract from Zika virus infection. PLoS Pathogens, 19(3), 1-26. DOI Scopus10 WoS3 Europe PMC8
2023	Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".. mSphere, 8(3), e0016523. DOI
2023	Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". mBio, 14(3), e0081523-1-e0081523-3. DOI
2023	Speck, P., Mackenzie, J., Bull, R. A., Slobedman, B., Drummer, H., Fraser, J., . . . Young, P. (2023). Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse". Journal of Virology, 97(5), 1-3. DOI
2023	Tan, B. E. K., Beard, M. R., & Eyre, N. S. (2023). Identification of Key Residues in Dengue Virus NS1 Protein That Are Essential for Its Secretion. Viruses, 15(5), 1-21. DOI Scopus5 WoS1 Europe PMC2
2022	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., . . . Lynn, D. J. (2022). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Medicine, 20(1), 26-1-26-23. DOI Scopus169 WoS91 Europe PMC130
2022	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk., B. (2022). SARS-CoV-2 Omicron variant escapes neutralising antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.. Cell Reports Medicine, 3(6), 23 pages. DOI Scopus25 WoS15 Europe PMC23
2022	Lim, C. K., Romeo, O., Chilver, A., Tran, B. M., Flanagan, D., Kirby, E., . . . Beard, M. (2022). Human Liver Organoids as a Patient-derived Model for HBV Infection and Cellular Response. DOI
2021	Crosse, K. M., Monson, E. A., Dumbrepatil, A. B., Smith, M., Tseng, Y. -Y., Van Der Hoek, K. H., . . . Helbig, K. J. (2021). Viperin binds STING and enhances the type-I interferon response following dsDNA detection. Immunology and Cell Biology, 99(4), 373-391. DOI Scopus26 WoS15 Europe PMC16
2021	Khantisitthiporn, O., Shue, B., Eyre, N. S., Nash, C. W., Turnbull, L., Whitchurch, C. B., . . . Beard, M. R. (2021). Viperin interacts with PEX19 to mediate peroxisomal augmentation of the innate antiviral response. Life Science Alliance, 4(7), e202000915-1-e202000915-14. DOI Scopus4 WoS3 Europe PMC2
2021	Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Lip Yeow, A. E., . . . Lynn, D. J. (2021). Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. DOI
2021	Shue, B., Chiramel, A. I., Cerikan, B., To, T. -H., Frolich, S., Pederson, S. M., . . . Beard, M. R. (2021). Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication. Journal of Virology, 95(24), e00596-21-1-e00596-21-18. DOI Scopus28 WoS11 Europe PMC24
2021	Al Shujairi, W. -H., Kris, L. P., Van Der Hoek, K., Cowell, E., Bracho-Granado, G., Woodgate, T., . . . Carr, J. M. (2021). Viperin is anti-viral in vitro but is dispensable for restricting dengue virus replication or induction of innate and inflammatory responses in vivo. Journal of General Virology, 102(10), 001669-1-001669-14. DOI Scopus6 WoS3 Europe PMC2
2021	Kirby, E. N., Shue, B., Thomas, P. Q., & Beard, M. R. (2021). CRISPR Tackles Emerging Viral Pathogens. Viruses, 13(11), 2157-1-2157-23. DOI Scopus7 WoS4 Europe PMC7
2021	Garcia-Valtanen, P., Hope, C. M., Masavuli, M. G., Yeow, A. E. L., Balachandran, H., Mekonnen, Z. A., . . . Grubor-Bauk, B. (2021). COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection. DOI
2020	Eyre, N. S., Kirby, E. N., Anfiteatro, D. R., Bracho, G., Russo, A. G., White, P. A., . . . Beard, M. R. (2020). Identification of estrogen receptor modulators as inhibitors of flavivirus infection. Antimicrob Agents Chemother, 8(64), 1-20. DOI Scopus13 WoS16 Europe PMC15
2020	Helbig, K. J., Bull, R. A., Ambrose, R., Beard, M. R., Blanchard, H., Böcking, T., . . . Tachedjian, G. (2020). Tenth Scientific Biennial Meeting of the Australasian Virology Society-AVS10 2019. Viruses, 12(6), 621-1-621-23. DOI
2020	Singleton, E. V., David, S. C., Davies, J. B., Hirst, T. R., Paton, J. C., Beard, M. R., . . . Alsharifi, M. (2020). Sterility of gamma-irradiated pathogens: a new mathematical formula to calculate sterilizing doses. Journal of Radiation Research, 61(6), 886-894. DOI Scopus14 WoS8 Europe PMC9
2020	Coldbeck-Shackley, R. C., Eyre, N. S., & Beard, M. R. (2020). The molecular interactions of ZIKV and DENV with the type-i IFN response. Vaccines, 8(3), 530-1-530-21. DOI Scopus26 WoS21 Europe PMC19
2019	Johnson, J., Freedman, H., Logan, M., Wong, J. A. J. -X., Hockman, D., Chen, C., . . . Houghton, M. (2019). A recombinant HCV genotype 1a E1/E2 envelope glycoprotein vaccine elicits antibodies that differentially neutralize closely related 2a strains through interactions of the N-terminal hypervariable region 1 of E2 with scavenger receptor B1. Journal of Virology, 93(22), e00810-19-1-e00810-19-15. DOI Scopus16 WoS13 Europe PMC10
2019	Helbig, K. J., Teh, M. Y., Crosse, K. M., Monson, E. A., Smith, M., Tran, E. N., . . . Beard, M. R. (2019). The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro.. Sci Rep, 9(1), 15598. DOI Scopus17 WoS16 Europe PMC11
2019	Grubor-Bauk, B., Wijesundara, D. K., Masavuli, M., Abbink, P., Peterson, R. L., Prow, N. A., . . . Gowans, E. J. (2019). NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.. Sci Adv, 5(12), eaax2388. DOI Scopus54 WoS36 Europe PMC37
2018	Shahrudin, S., Chen, C., David, S., Singleton, E., Davies, J., Kirkwood, C., . . . Alsharifi, M. (2018). Gamma-irradiated rotavirus: a possible whole virus inactivated vaccine. PLoS ONE, 13(6), e0198182-1-e0198182-15. DOI Scopus15 WoS13 Europe PMC12
2018	Adikusuma, F., Piltz, S., Corbett, M. A., Turvey, M., McColl, S. R., Helbig, K. J., . . . Thomas, P. Q. (2018). Large deletions induced by Cas9 cleavage. Nature, 560(7717), E8-E9. DOI Scopus243 WoS188 Europe PMC200
2017	Eyre, N., Aloia, A., Joyce, M., Chulanetra, M., Tyrrell, L., & Beard, M. (2017). Sensitive luminescent reporter viruses reveal appreciable release of hepatitis C virus NS5A protein into the extracellular environment. Virology, 507, 20-31. DOI Scopus18 WoS15 Europe PMC12
2017	Van Der Hoek, K., Eyre, N., Shue, B., Khantisitthiporn, O., Glab-Ampi, K., Carr, J., . . . Beard, M. (2017). Viperin is an important host restriction factor in control of Zika virus infection. Scientific Reports, 7(1), 4475 -1-4475-14. DOI Scopus91 WoS87 Europe PMC67
2017	Nasr, N., Alshehri, A. A., Wright, T. K., Shahid, M., Heiner, B. M., Harman, A. N., . . . Cunningham, A. L. (2017). Mechanism of interferon stimulated gene induction in HIV-1 infected macrophages. Journal of Virology, 91(20), e00744-17-1-e00744-17-47. DOI Scopus42 WoS37 Europe PMC39
2017	Eyre, N., Johnson, S., Eltahla, A., Aloi, M., Aloia, A., McDevitt, C., . . . Beard, M. (2017). Genome-wide mutagenesis of dengue virus reveals plasticity of the NS1 protein and enables generation of infectious tagged reporter viruses. Journal of Virology, 91(23), e01455-17-1-e01455-17-25. DOI Scopus25 WoS22 Europe PMC20
2017	Crosse, K., Monson, E., Beard, M., & Helbig, K. (2017). Interferon-stimulated genes as enhancers of antiviral innate immune signaling. Journal of Innate Immunity, 10(2), 85-93. DOI Scopus129 WoS78 Europe PMC93
2016	Clarke, J., Davies, L., Calvert, J., Gliddon, B., Al Shujari, W., Aloia, A., . . . Carr, J. (2016). Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. Journal of General Virology, 97(1), 95-109. DOI Scopus17 WoS15 Europe PMC13
2016	Eyre, N., Hampton-Smith, R., Aloia, A., Eddes, J., Simpson, K., Hoffmann, P., & Beard, M. (2016). Phosphorylation of NS5A Serine-235 is essential to hepatitis C virus RNA replication and normal replication compartment formation. Virology, 491, 27-44. DOI Scopus29 WoS24 Europe PMC25
2016	Fiches, G., Eyre, N., Aloia, A., Van Der Hoek, K., Betz-Stablein, B., Luciani, F., . . . Beard, M. (2016). HCV RNA traffic and association with NS5A in living cells. Virology, 493, 60-74. DOI Scopus8 WoS7 Europe PMC8
2016	Awan, Z., Tay, E., Eyre, N., Wu, L., Beard, M., Boo, I., . . . Douglas, M. (2016). Calsyntenin-1 mediates hepatitis C virus replication. Journal of General Virology, 97(8), 1877-1887. DOI Scopus4 WoS4 Europe PMC4
2015	Aloia, A., Eyre, N., Black, S., Bent, S., Gaeguta, A., Guo, Z., . . . Beard, M. (2015). Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations.. Antiviral therapy, 20(3), 271-280. DOI Scopus3 WoS2 Europe PMC3
2015	Tse, E., Helbig, K., Van der Hoek, K., McCartney, E., Van der Hoek, M., George, J., & Beard, M. (2015). Fatty acids induce a pro-inflammatory gene expression profile in Huh-7 cells that attenuates the anti-HCV action of interferon. Journal of Interferon and Cytokine Research, 35(5), 392-400. DOI Scopus15 WoS13 Europe PMC6
2015	Mina, M., Luciani, F., Cameron, B., Bull, R., Beard, M., Booth, D., & Lloyd, A. (2015). Resistance to hepatitis C virus: potential genetic and immunological determinants. The Lancet Infectious Diseases, 15(4), 451-460. DOI Scopus20 WoS19 Europe PMC14
2015	Milic, N., Davis, S., Carr, J., Isberg, S., Beard, M., & Helbig, K. (2015). Sequence analysis and characterisation of virally induced viperin in the saltwater crocodile (Crocodylus porosus). Developmental and Comparative Immunology, 51(1), 108-115. DOI Scopus10 WoS10 Europe PMC5
2015	Calvert, J., Helbig, K., Dimasi, D., Cockshell, M., Beard, M., Pitson, S., . . . Carr, J. (2015). Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 35(8), 654-665. DOI Scopus28 WoS24 Europe PMC19
2015	Narayana, S., Helbig, K., McCartney, E., Eyre, N., Bull, R., Eltahla, A., . . . Beard, M. (2015). The interferon-induced transmembrane proteins, IFITM1, IFITM2 and IFITM3 inhibit hepatitis C virus entry. Journal of Biological Chemistry, 290(43), 25946-25959. DOI Scopus125 WoS108 Europe PMC108
2015	Green, T., Speck, P., Geng, L., Raftos, D., Beard, M., & Helbig, K. (2015). Oyster viperin retains direct antiviral activity and its transcription occurs via a signalling pathway involving a heat-stable haemolymph protein. Journal of General Virology, 96(12), 3587-3597. DOI Scopus28 WoS21 Europe PMC10
2014	Eyre, N. S., & Beard, M. R. (2014). HCV NS5A inhibitors disrupt replication factory formation: a novel mechanism of antiviral action. Gastroenterology, 147(5), 959-962. DOI Scopus11 Europe PMC7
2014	Eyre, N. S., & Beard, M. R. (2014). A mechanism for HCV NS5A-directed antiviral therapy. Gastroenterology, 147(5), 946-947. DOI WoS2
2014	Eyre, N., Helbig, K., & Beard, M. (2014). Current and future targets of antiviral therapy in the hepatitis C virus life cycle. Future Virology, 9(11), 947-965. DOI Scopus3 WoS3
2014	Beard, M. R., Ffrench, R., Gowans, E. J., Helbig, K. J., Eyre, N. M., Douglas, M. M. W., . . . Drummer, H. E. (2014). A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology, 147(1), e1-e4. DOI Scopus1 WoS1
2014	Helbig, K., & Beard, M. (2014). The role of viperin in the innate antiviral response. Journal of Molecular Biology, 426(6), 1210-1219. DOI Scopus165 WoS155 Europe PMC117
2014	Eyre, N., Fiches, G., Aloia, A., Helbig, K., McCartney, E., McErlean, C., . . . Beard, M. (2014). Dynamic imaging of the hepatitis C virus NS5A protein during a productive infection. Journal of Virology, 88(7), 3636-3652. DOI Scopus46 WoS41 Europe PMC35
2013	McCartney, E., Helbig, K., Narayana, S., Eyre, N., Aloia, A., & Beard, M. (2013). Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology, 58(5), 1558-1568. DOI Scopus53 WoS49 Europe PMC47
2013	Carr, J., Kua, T., Clarke, J., Calvert, J., Zebol, J., Beard, M., & Pitson, S. (2013). Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3' untranslated region of dengue virus type-2 RNA. Journal of General Virology, 94(PART 11), 2437-2448. DOI Scopus28 WoS25 Europe PMC22
2013	Moriconi, F., Beard, M., & Yuen, L. (2013). Bioinformatics methods for the analysis of hepatitis viruses. Antiviral Therapy, 18(3 PARTB), 531-539. DOI Scopus3 WoS3
2013	Helbig, K., Carr, J., Calvert, J., Wati, S., Clarke, J., Eyre, N., . . . Beard, M. (2013). Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Neglected Tropical Diseases, 7(4), 1-14. DOI Scopus130 WoS120 Europe PMC89
2012	Aloia, A., Locarnini, S., & Beard, M. (2012). Antiviral resistance and direct-acting antiviral agents for HCV. Antiviral Therapy, 17(6 PART B), 1147-1162. DOI Scopus24 WoS23 Europe PMC20
2012	Nasr, N., Maddocks, S., Turville, S., Harman, A., Woolger, N., Helbig, K., . . . Cunningham, A. (2012). HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood, 120(4), 778-788. DOI Scopus183 WoS168 Europe PMC149
2012	Phillips, R., Helbig, K., Van Der Hoek, K., Seth, D., & Beard, M. (2012). Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World Journal of Gastroenterology, 18(26), 3389-3399. DOI Scopus33 WoS27 Europe PMC24
2012	Helbig, K., & Beard, M. (2012). The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment. Biomarkers in Medicine, 6(2), 141-150. DOI Scopus4 WoS5 Europe PMC4
2012	Keoshkerian, E., Helbig, K., Beard, M., Zaunders, J., Seddiki, N., Kelleher, A., . . . Lloyd, A. (2012). A novel assay for detection of hepatitis C virus-specific effector CD4⁺ T cells via co-expression of CD25 and CD134. Journal of Immunological Methods, 375(1-2), 148-158. DOI Scopus28 WoS27 Europe PMC21
2011	Suzuki, T., Ishida, T., Yamagishi, M., Ahlenstiel, C., Swaminathan, S., Marks, K., . . . Kelleher, A. (2011). Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific. RNA Biology, 8(6), 1035-1046. DOI Scopus39 WoS34 Europe PMC34
2011	Helbig, K., Eyre, N., Yip, L., Narayana, S., Li, K., Fiches, G., . . . Beard, M. (2011). The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology, 54(5), 1506-1517. DOI Scopus167 WoS156 Europe PMC128
2011	Fernandez, S., Tanaskovic, S., Helbig, K., Rajasuriar, R., Kramski, M., Murray, J., . . . French, M. (2011). CD4⁺ T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4⁺ T cells. Journal of Infectious Diseases, 204(12), 1927-1935. DOI Scopus98 WoS90 Europe PMC81
2011	Berzsenyi, M., Woollard, D., McLean, C., Preiss, S., Perreau, V., Beard, M., . . . Roberts, S. (2011). Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. Journal of Hepatology, 55(3), 536-544. DOI Scopus18 WoS14 Europe PMC13
2011	McCartney, E., Eyre, N., & Beard, M. (2011). Border patrol intensifies for hepatitis C virus entry. Hepatology, 54(4), 1472-1475. DOI Scopus2 Europe PMC1
2011	Wati, S., Rawlinson, S., Ivanov, R., Dorstyn, L., Beard, M., Jans, D., . . . Carr, J. (2011). Tumour necrosis factor alpha (TNF-α) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-α to activate nuclear factor κB and reduced sphingosine kinase-1 activity. Journal of General Virology, 92(4), 807-818. DOI Scopus43 WoS40 Europe PMC33
2011	Berzsenyi, M., Roberts, S., Preiss, S., Woollard, D., Beard, M., Skinner, N., . . . Visvanathan, K. (2011). Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection. Journal of Viral Hepatitis, 18(12), 852-860. DOI Scopus45 WoS44 Europe PMC31
2011	Thompson, A. J., Locarnini, S. A., & Beard, M. R. (2011). Resistance to anti-HCV protease inhibitors. Current Opinion in Virology, 1(6), 599-606. DOI Scopus36 WoS36 Europe PMC25
2010	Eyre, N., Drummer, H., & Beard, M. (2010). The SR-BI partner PDZK1 facilitates Hepatitis C virus entry. PLoS Pathogens, 6(10), 1-14. DOI Scopus51 WoS43 Europe PMC34
2010	Osna, N., White, R., Donohue, T., Beard, M., Tuma, D., & Kharbanda, K. (2010). Impaired methylation as a novel mechanism for proteasome suppression in liver cells. Biochemical and Biophysical Research Communications, 391(2), 1291-1296. DOI Scopus30 WoS26 Europe PMC24
2010	Eyre, N., & Beard, M. (2010). Hepatitis C virus infection in living color. Hepatology, 51(5), 1852-1855. DOI Scopus1 Europe PMC1
2010	McCartney, E., & Beard, M. (2010). Impact of alcohol on hepatitis C virus replication and interferon signaling. World Journal of Gastroenterology, 16(11), 1337-1343. DOI Scopus37 WoS31 Europe PMC27
2009	Wati, S., Soo, M., Zilm, P., Li, P., Paton, A., Burrell, C., . . . Carr, J. (2009). Dengue Virus infection induces upregulation of GRP78, which acts to chaperone viral antigen production. Journal of Virology, 83(24), 12871-12880. DOI Scopus90 WoS72 Europe PMC70
2009	Eyre, N., Baumert, T., & Beard, M. (2009). Closing the gap: The tight junction protein occludin and hepatitis C virus entry. Hepatology, 49(5), 1770-1772. DOI Scopus1 Europe PMC1
2009	Eyre, N., Phillips, R., Bowden, S., Yip, L., Dewar, B., Locarnini, S., & Beard, M. (2009). Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells. Journal of Hepatology, 51(3), 446-457. DOI Scopus71 WoS61 Europe PMC46
2009	Helbig, K., Ruszkiewicz, A., Lanford, R., Berzsenyi, M., Harley, H., McColl, S., & Beard, M. (2009). Differential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In Vitro. Journal of Virology, 83(2), 836-846. DOI Scopus62 WoS59 Europe PMC42
2008	Beard, M., & Helbig, K. (2008). Control of HCV replication: When size does not matter. Hepatology, 47(3), 1092-1094. DOI Scopus1
2008	McCartney, E., Semendric, L., Helbig, K., Hinze, S., Jones, B., Weinman, S., & Beard, M. (2008). Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. Journal of Infectious Diseases, 198(12), 1766-1775. DOI Scopus50 WoS44 Europe PMC37
2008	Helbig, K., Yip, L., McCartney, E., Eyre, N., & Beard, M. (2008). A screening method for identifying disruptions in interferon signaling reveals HCVNS3/4a disrupts Stat-1 phosphorylation. Antiviral Research, 77(3), 169-176. DOI Scopus12 WoS11 Europe PMC11
2007	Phillips, R. J., Helbig, K. J., Ruszkiewicz, A. R., & Beard, M. R. (2007). Osteopontin is significantly expressed in advanced HCV-related liver disease and can accelerate huh-7 cell growth in vitro and in a nude mouse model. JOURNAL OF HEPATOLOGY, 46, S145. DOI
2006	Beard, M., & Jones, B. (2006). Hepatitis C virus and oxidative stress: a dangerous liaison. Future Virology, 1(2), 223-232. DOI WoS8
2006	Berzsenyi, M., Roberts, S., & Beard, M. (2006). Genomics of hepatitis B and C infections: diagnostic and therapeutic applications of microarray profiling. Antiviral Therapy, 11(5), 541-552. DOI Scopus9 WoS6 Europe PMC5
2005	Helbig, K., Lau, D., Semendric, L., Harley, H., & Beard, M. (2005). Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology, 42(3), 702-710. DOI Scopus208 WoS204 Europe PMC160
2005	Lau, D., Luxon, B., Xiao, S., Beard, M., & Lemon, S. (2005). Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology, 42(2), 273-281. DOI Scopus60 WoS55 Europe PMC45
2005	Helbig, K., George, J., & Beard, M. (2005). A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro. Journal of Clinical Virology, 32(2), 137-143. DOI Scopus13 WoS14 Europe PMC12
2005	Locarnini, S., Shaw, T., Dean, J., Colledge, D., Thompson, A., Li, K., . . . Beard, M. (2005). Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. Journal of Clinical Virology, 32(2), 113-121. DOI Scopus24 WoS18 Europe PMC14
2005	Otani, K., Korenaga, M., Beard, M., Li, K., Qian, T., Showalter, L., . . . Weinman, S. (2005). Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology, 128(1), 96-107. DOI Scopus124 WoS112 Europe PMC93
2004	Beard, M. (2004). Clinical outcome to interferon therapy in chronic hepatitis C: insights from mechanistic studies. Antiviral Therapy, 9(5), 637-639. DOI
2004	Bigger, C., Guerra, B., Brasky, K., Hubbard, G., Beard, M., Luxon, B., . . . Lanford, R. (2004). Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. Journal of Virology, 78(24), 13779-13792. DOI Scopus243 WoS222 Europe PMC198
2004	Helbig, K., Ruszkiewicz, A., Semendric, L., Harley, H., McColl, S., & Beard, M. (2004). Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology, 39(5), 1220-1229. DOI Scopus108 WoS101 Europe PMC81
2004	Beard, M. R., & Locarnini, S. (2004). Monitoring gene expression using DNA microarrays during hepatitis B virus infection.. Methods in molecular medicine, 96, 55-64. DOI
2002	Lerat, H., Honda, M., Beard, M. R., Loesch, K., Sun, J., Yang, Y., . . . Lemon, S. M. (2002). Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology, 122(2), 352-365. DOI Scopus420 WoS375 Europe PMC301
2002	Okuda, M., Li, K., Beard, M. R., Showalter, L. A., Scholle, F., Lemon, S. M., & Weinman, S. A. (2002). Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 122(2), 366-375. DOI Scopus840 WoS745 Europe PMC586
2002	Li, K., Prow, T., Lemon, S. M., & Beard, M. R. (2002). Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology, 35(5), 1237-1246. DOI Scopus91 WoS88 Europe PMC59
2001	Gale, M., & Beard, M. R. (2001). Molecular clones of hepatitis C virus: Applications to animal models. ILAR Journal, 42(2), 139-151. DOI Scopus16 Europe PMC11
2001	Beard, M. R., Cohen, L., Lemon, S. M., & Martin, A. (2001). Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction. Journal of Virology, 75(3), 1414-1426. DOI Scopus31 WoS24 Europe PMC19
2001	Xiao, S. Y., Wang, H. L., Hart, J., Fleming, D., & Beard, M. R. (2001). Cdna arrays and immunohistochemistry identification of cd10/calla expression in hepatocellular carcinoma. American Journal of Pathology, 159(4), 1415-1421. DOI Scopus73 WoS68 Europe PMC50
2000	Lemon, S. M., Lerat, H., Honda, M., Loesch, K., West, B., Okuda, M., . . . Weinman, S. A. (2000). Hepatic Steatosis and Hepatocellular Carcinoma in Hepatitis C Transgenic Mice. Acta Hepatologica Japonica, 41(supl1), A27-A32. DOI
2000	Blank, C. A., Anderson, D. A., Beard, M., & Lemon, S. M. (2000). Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: Vectorial release of progeny virions through apical cellular membranes. Journal of Virology, 74(14), 6476-6484. DOI Scopus63 WoS49 Europe PMC38
1999	Honda, M., Beard, M. R., Ping, L. H., & Lemon, S. M. (1999). A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap- independent viral translation. Journal of Virology, 73(2), 1165-1174. DOI Scopus245 WoS218 Europe PMC173
1999	Beard, M. R., Abell, G., Honda, M., Carroll, A., Gartland, M., Clarke, B., . . . Lemon, S. M. (1999). An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology, 30(1), 316-324. DOI Scopus122 WoS109 Europe PMC101
1996	Beard, M. R., MacNaughton, T. B., & Gowans, E. J. (1996). Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. Journal of Virology, 70(8), 4986-4995. DOI Scopus65 WoS62 Europe PMC46
1993	Macnaughton, T. B., Beard, M. R., Chao, M., Gowans, E. J., & Lai, M. M. C. (1993). Endogenous Promoters Can Direct the Transcription of Hepatitis Delta Virus RNA from a Recircularized cDNA Template. Virology, 196(2), 629-636. DOI Scopus37 WoS34 Europe PMC23

Book Chapters

Year	Citation
2012	Tse, E., & Beard, M. (2012). Mechanisms of action of antiviral drugs: the interferons. In G. McCaughan, J. McHutchison, & J. -M. Pawlotsky (Eds.), Advanced therapy for hepatitis C (pp. 25-35). United Kingdom: Wiley-Blackwell. DOI
2012	Beard, M. (2012). HCV replication. In G. McCaughan, J. McHutchison, & J. -M. Pawlotsky (Eds.), Advanced therapy for hepatitis C (pp. 1-11). United Kingdom: Wiley-Blackwell. DOI
2009	Eyre, N., & Beard, M. (2009). HCV Virology. In G. Dore, M. Temple-Smith, & A. Lloyd (Eds.), Hepatitis C. An expanding perspective (pp. 3-26). Victoria, Australia: IP Communications.

Conference Papers

Year	Citation
2018	Colledge, D., Jackson, K., Sozzi, V., Li, X., Beard, M. R., Eyre, N., . . . Locarnini, S. (2018). Inarigivir Is a Novel Selective Inhibitor of the HBV Replicase Complex in Vitro. In HEPATOLOGY Vol. 68 (pp. 229A). San Francisco, CA: WILEY. WoS4
2016	Mitra, A., MacIntyre, D., Lee, Y., Smith, A., Marchesi, J., Lehne, B., . . . Kyrgiou, M. (2016). Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. In BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY Vol. 123 (pp. E11-E12). WILEY-BLACKWELL.
2011	McCartney, E. M., Helbig, K. J., & Beard, M. R. (2011). THE ROLE OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) IN THE HCV LIFE CYCLE. In JOURNAL OF HEPATOLOGY Vol. 54 (pp. S307). Berlin, GERMANY: ELSEVIER. DOI
2010	Eyre, N. S., Turville, S., & Beard, M. (2010). LIVE CELL IMAGING OF HEPATITIS C VIRUS NS5A TRAFFIC DURING AN INFECTIOUS LIFE CYCLE. In HEPATOLOGY Vol. 52 (pp. 376A-377A). Boston, MA: WILEY-BLACKWELL.
2009	Berzsenyi, M. D., Woollard, D. J., McLean, C. A., Preiss, S., Perreau, V. M., Beard, M. R., . . . Roberts, S. K. (2009). DIFFERENTIAL INTRA-HEPATIC T-CELL SIGNALLING ASSOCIATED WITH GB VIRUS C IN HCV/HIV CO-INFECTION. In HEPATOLOGY Vol. 50 (pp. 949A). Boston, MA: JOHN WILEY & SONS INC.
2009	Austin, L., Kharbanda, K. K., Beard, M. R., & Osna, N. A. (2009). ETHANOL AFFECTS EXPRESSION OF RECEPTORS FOR HCV ENTRY IN LIVER CELLS. In HEPATOLOGY Vol. 50 (pp. 1155A-1156A). Boston, MA: JOHN WILEY & SONS INC. WoS2
2008	Osna, N. A., Donohue, T. M., White, R. L., Beard, M. R., & Kharbanda, K. K. (2008). ETHANOL AND HEPATITIS C VIRAL (HCV) PROTEINS REGULATE INTERFERON (IFN) SIGNALING IN LIVER CELLS VIA IMPAIRED METHYLATION OF STAT1. In HEPATOLOGY Vol. 48 (pp. 327A-328A). San Francisco, CA: JOHN WILEY & SONS INC. WoS5
2006	Seth, D., Beard, M. R., Gorrell, M. D., McCaughan, G. W., & Haber, P. S. (2006). Osteopontin: An early marker for alcoholic liver injury?. In ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH Vol. 30 (pp. 89A). Sydney, AUSTRALIA: BLACKWELL PUBLISHING. WoS2
2004	Helbig, K. J., Semendric, L., & Beard, M. R. (2004). <i>In vitro</i> modulation of the CXCR3 chemokine I-TAC by HCV replication is influenced by a novel I-TAC promoter polymorphic variant.. In HEPATOLOGY Vol. 40 (pp. 438A). Boston, MA: JOHN WILEY & SONS INC.
2004	Beard, M. R., Semendric, L., Helbig, K. J., Otani, K., & Weinman, S. A. (2004). HCV replication is enhanced in the presence of CYP2E1 and alcohol. In HEPATOLOGY Vol. 40 (pp. 198A-199A). Boston, MA: JOHN WILEY & SONS INC.
2002	Shaw, T., Dean, J., Locarnini, S., & Beard, M. R. (2002). DNA microarray analyses show that lamivudine affects gene expression in HEPG2 cells: Implications for chemotherapy of chronic HBV infection. In HEPATOLOGY Vol. 36 (pp. 633A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
2002	Otani, K., Beard, M. R., & Weinman, S. A. (2002). Cellular models for the study of alcohol-hepatitis C interactions.. In HEPATOLOGY Vol. 36 (pp. 398A). BOSTON, MASSACHUSETTS: W B SAUNDERS CO.
2002	Lau, D. T. Y., Ma, H. B., Abdo, B. O., Luxon, B. A., Sinha, M., & Beard, M. R. (2002). Differential hepatic gene expression profiles between steatosis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). In GASTROENTEROLOGY Vol. 122 (pp. A672). W B SAUNDERS CO.

Conference Items

Year	Citation
2019	Colledge, D., Jackson, K., Sozzi, V., Li, X., Beard, M., Eyre, N., . . . Locarnini, S. (2019). The novel antiviral agent inarigivir inhibits both nucleos (t)ide analogue and capsid assembly inhibitor resistant HBV in vitro. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Vienna, AUSTRIA: ELSEVIER. DOI
2019	Lim, C. K., Tran, B. M., Shue, B., Eyre, N., Flanagan, D., Vincan, E., . . . Beard, M. (2019). Human liver organoids culture as a novel in vitro model of HBV infection. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Vienna, AUSTRIA: ELSEVIER.
2014	Tse, E. Y., Helbig, K. J., Van der Hoek, K., McCartney, E. M., George, J., & Beard, M. R. (2014). FATTY ACIDS INDUCE A PRO-INFLAMMATORY GENE EXPRESSION PROFILE IN HUH-7 CELLS AND ATTENUATE THE ANTI-HCV ACTION OF INTERFERON. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. London, ENGLAND: ELSEVIER SCIENCE BV. DOI
2013	Muller, K. R., Eyre, N. S., Van der Hoek, K. H., Li, K., & Beard, M. R. (2013). The effect of hepatitis C virus-infected Huh-7 cells on 'bystander' cells. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Melbourne, Vic.: Wiley. DOI
2012	Aloia, A. L., Carr, J., Eyre, N. S., Locarnini, S., Lemon, S., & Beard, M. R. (2012). Development of a genotype 6a/1b chimeric replicon for testing of direct acting antivirals against the HCV protease. Poster session presented at the meeting of HEPATOLOGY. Boston, MA: WILEY-BLACKWELL.
2009	Berzsenyi, M. D., Woollard, D. J., McLean, C. A., Preiss, S., Perreau, V. M., Beard, M. R., . . . Roberts, S. K. (2009). Differential intra-hepatic T-cell signalling associated with GB virus C in HCV/HIV co-infection. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC.

Preprint

Year	Citation
2024	Cadilhac, D., Ross, A., Bagot, K., Blennerhassett, J., Kilkenny, M., Kim, J., . . . Middleton, S. (2024). Protocol for a feasibility registry-based randomised controlled trial investigating a tailored follow-up service for stroke (A-LISTS). DOI
2024	Johnson, S. M., Centofanti, S. M., Bracho, G., Beard, M. R., Carr, J. M., & Eyre, N. S. (2024). Coatomer protein complex I is required for efficient secretion of dengue virus non-structural protein 1. DOI
2023	Kirby, E., Montin, X., Allen, T., Densumite, J., Trowbridge, B., & Beard, M. (2023). The utility of CRISPR activation as a platform to identify interferon stimulated genes with anti-viral function. DOI

2020. Beard M; Lim C; Warner N. Liver organoid culture as a platform for novel HBV antiviral testing. Australian Centre for HIV and Hepatitis Virology Research. $85,000.00

2020-2022 Doonan C; Sumby C; Bell S; Beard M; Falcaro P. Advancing the Chemistry of Metal-organic Frameworks for Biotechnology. ARC DP200102411. $550,000.00

2018-2020. Beard, Helbig, Lemon, Eyre. NHMRC Project Grant APP1145613. The interplay between viperin, peroxisomes and the cellular innate antiviral response. $556,127

2014-2018 Lloyd, Dore, George, Beard. NHMRC Program Grant APP1053206. Title: Hepatitis C infection: epidemiology pathogenesis and treatment. $5,427,855.00

2015-2016 KJ Helbig, MR Beard, P Revill, P Thomas. Targeting HBV cccDNA using the CRISPR/Cas system. $169,000. Australian Centre for HIV and Hepatitis Virology Research

2010-2015 Beard M. NHMRC Senior Research Fellowship $560,000 total

2009-2013 Cooper, Beard, Dore, Emery, French, Kelleher, Kent, Purcell. NHMRC Program Grant #510448. Title: HIV and HCV Vaccines and Immunopathogenesis. $17,800,000 ($395,000/year/investigator)

2012-2014 Michael Beard, Nicholas Eyre and Stuart Turville. (2012-2014) Imaging the hepatitis C virus life cycle in living cells. NHMRC Project Grant APP1027641 Total: $461,325.000

2012 Michael Beard, Jill Carr and Stephen Locarnini. Analysis of Boceprevir drug susceptibility and resistance in HCV genotype 6. Merck Investigator Studies Program $115,000

2011-2012 Beard M and Locarnini S. Phase II. Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds. ACH2 $113,000 tot

2010-2011 Beard M and Locarnini S. Development of a laboratory based platform to manage patients who develop antiviral drug-resistance to the STAT-C compounds. ACH2 $142,000 total

2010-2011 Beard M and Shackel N. Ultra-deep sequencing of hepatitis C and hepatocytes following interferon exposure Roche Pillar Award. $40,000 total

2008-2010 Beard M & Helbig K. NHMRC Project Grant # 508088 Identification of interferon stimulated genes that limit HCV replication and predict therapeutic outcome. $468,750 total

Current Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2024	Co-Supervisor	Harnessing the potential of mRNA vaccines against Hepatitis C Virus	Doctor of Philosophy	Doctorate	Full Time	Mr John Henrik Johansson
2022	Principal Supervisor	CRISPR Screening Systems to Identify Novel Virus-Host Interactions and Innate Immune Pathways	Doctor of Philosophy	Doctorate	Full Time	Mr Xavier Bernard Montin
2021	Principal Supervisor	The Impact of Hypoxia on Flavivirus Infection and Innate Immune Responses	Doctor of Philosophy	Doctorate	Full Time	Miss Brooke Nyree Trowbridge

Past Higher Degree by Research Supervision (University of Adelaide)

Date	Role	Research Topic	Program	Degree Type	Student Load	Student Name
2020 - 2023	Principal Supervisor	Identification of dengue virus (DENV) NS1 protein residues involved in its cellular secretion and host factors involved in NS1 protein N-glycosylation	Doctor of Philosophy	Doctorate	Full Time	Mr Eng Kuan Brandon Tan
2019 - 2023	Principal Supervisor	CRISPR Activation as a Tool to Identify Anti-viral Host Factors	Doctor of Philosophy	Doctorate	Full Time	Miss Emily Nicole Kirby
2018 - 2021	Principal Supervisor	Molecular Characterisation of Flavivirus Interactions with the Host Innate Immune Response	Doctor of Philosophy	Doctorate	Full Time	Ms Rosa Cedar Coldbeck-Shackley
2017 - 2020	Co-Supervisor	Sterility and Immunogenicity of Gamma Irradiated Respiratory Viruses	Doctor of Philosophy	Doctorate	Full Time	Miss Eve Victoria Singleton
2017 - 2022	Principal Supervisor	Human Liver Organoids Culture as a Personalised Approach in Assessing HBV Infection and Cellular Responses	Doctor of Philosophy	Doctorate	Full Time	Dr Chuan Kok Lim
2015 - 2021	Principal Supervisor	Identification of Proviral and Host Restriction Factors that Impact the Flaviviridae Lifecycle	Doctor of Philosophy	Doctorate	Full Time	Mr Byron Shue
2013 - 2018	Principal Supervisor	The Novel Interacting Partners of Viperin and their Role in Establishing a Host Antiviral State	Doctor of Philosophy	Doctorate	Full Time	Ms Onruedee Khantisitthiporn
2011 - 2015	Principal Supervisor	Defining and Characterising the anti-HCV Actions of the Interferon-Induced Transmembrane Proteins	Doctor of Philosophy	Doctorate	Full Time	Miss Sumudu Kumari Narayana
2011 - 2015	Principal Supervisor	Dynamic Imaging of Hepatitis C Virus RNA Localisation and Traffic During Viral Replication	Doctor of Philosophy	Doctorate	Full Time	Mr Guillaume Fiches
2010 - 2015	Principal Supervisor	The Bystander Effect in Hepatitis C Virus Infection: Cellular Interactions Between Infected Cells and Uninfected Cells	Doctor of Philosophy	Doctorate	Full Time	Ms Kate Rebecca Muller
2009 - 2015	Principal Supervisor	Improving treatment predictors of HCV therapy and the impact of steatosis on the hepatocyte transcriptome and anti-HCV action of interferon	Doctor of Philosophy	Doctorate	Part Time	APrf Edmund Yee-Lai Tse
2007 - 2012	Co-Supervisor	Molecular Analysis of Acute and Chronic Duck Hepatitis B Virus (DHBV) Infections in Ducks	Doctor of Philosophy	Doctorate	Full Time	Miss Huey Low
2007 - 2014	Co-Supervisor	DEVELOPMENT AND ASSESSMENT OF NOVEL VACCINATION STRATEGIES FOR HEPATITIS B VIRUS INFECTION	Doctor of Philosophy	Doctorate	Full Time	Mr Devin Teoh
2006 - 2011	Principal Supervisor	Molecular Interactions Between Alcohol, Hepatitis C Virus and Interferon	Doctor of Philosophy	Doctorate	Full Time	Dr Erin McCartney
2005 - 2010	Co-Supervisor	Development of Antiviral Therapies for Hepatitis B Virus Infection	Doctor of Philosophy	Doctorate	Full Time	Miss Faseeha Noordeen
2004 - 2008	Co-Supervisor	Characterisation of the Events Involved in the Resolution of Acute Duck Hepatitis B Virus Infection	Doctor of Philosophy	Doctorate	Full Time	Dr Georget Reaiche
2004 - 2010	Principal Supervisor	Expression and function of osteopontin variants in HCV-related liver disease and hepato-cellular carcinoma	Doctor of Philosophy	Doctorate	Full Time	Dr Renee Phillips

Committee Memberships

Date	Role	Committee	Institution	Country
2015 - ongoing	Member	Lorne Infection and Immunity Conference	-	-
2010 - ongoing	Member	Organising Committee International Symposium on HCV and Related Viruses	-	-

Editorial Boards

Date	Role	Editorial Board Name	Institution	Country
2017 - ongoing	Associate Editor	Virology Journal	-	-
2013 - ongoing	Advisory Board Member	Journal of Interferon and Cytokine Research	-	-

Position: Professor
Phone: 83135522
Email: michael.beard@adelaide.edu.au
Campus: North Terrace
Building: Molecular Life Sciences, floor Third Floor
Room: 333
Org Unit: Molecular and Biomedical Science